Wednesday, January 11, 2023: Life Sciences

The Food and Drug Administration (FDA) said its advisory panel will meet on February 15 to review Emergent Biosolutions Inc’s over-the-counter nasal spray to treat suspected opioid overdoses. Emergent is asking the FDA to approve for the prescription-free sale...